CD38 inhibition: Apigenin is a potent natural inhibitor of CD38, the enzyme that consumes NAD+ in tissues. CD38 expression increases significantly with aging, contributing to age-related NAD+ decline. By inhibiting CD38, apigenin preserves cellular NAD+ pools, supporting sirtuin function (SIRT1, SIRT3), mitochondrial health, and DNA repair. This is the basis for its inclusion in longevity protocols (Sinclair Lab popularized this).
GABA-A modulation: Apigenin binds the benzodiazepine site of GABA-A receptors, providing mild anxiolytic and sedative effects. This is the primary mechanism behind chamomile tea's traditional calming reputation.
Aromatase inhibition: Apigenin is a mild aromatase inhibitor (the enzyme converting testosterone to estradiol). Effect is modest compared to pharmaceutical aromatase inhibitors but relevant for those tracking estrogen.
MAO-A inhibition: Mild reversible MAO-A inhibitor, contributing to mood support via increased serotonin and norepinephrine availability.
Anti-inflammatory: NF-kB inhibition reduces pro-inflammatory cytokine production. COX-2 inhibition reduces inflammatory prostaglandin synthesis.
Antioxidant: Direct ROS scavenging and Nrf2 pathway activation inducing endogenous antioxidant enzymes.
Anti-cancer: In vitro and animal studies show apigenin selectively induces apoptosis in cancer cells via modulation of PI3K/Akt, p53, and cell cycle pathways. Clinical evidence in humans is preliminary.
Neuroprotection: Reduces neuroinflammation, supports BDNF expression, and modulates glutamate receptor function in CNS.